Parkinson's Disease Trial, Recruiting (NCT07384143)

Parkinson's Disease Trial, Recruiting NCT07384143 Sponsor: IRCCS Centro Neurolesi Bonino Pulejo Condition: Parkinson's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07384143 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Parkinsons Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 18 and 75 years old.
You have a very limited ability to move your arm and hand (scored 0–31 on a specialist assessment), making you eligible for robotic devices that provide a high level of physical support.
You have a moderate ability to move your arm and hand (scored 32–47 on a specialist assessment), making you eligible for devices that provide a medium level of physical support.
You have a near-normal but still reduced ability to move your arm and hand (scored 48–52 on a specialist assessment), making you eligible for sensor-based devices that provide a low level of physical support.
You have a score of 20 or below on a standard memory and thinking assessment called the MoCA.

Who may not be able to join:

You have severe problems with memory, thinking, or understanding (confirm with trial site).
You have significant difficulties with behaviour (confirm with trial site).
You have significant problems with your senses, such as touch, sight, or hearing (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +393458747117

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07384143

Sponsor: IRCCS Centro Neurolesi Bonino Pulejo

Phase: Not Applicable

Status: Recruiting

Condition: Parkinson's Disease

Trial contact: +393458747117

More information: https://clinicaltrials.gov/study/NCT07384143

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 18 and 75 years old.
You have a very limited ability to move your arm and hand (scored 0–31 on a specialist assessment), making you eligible for robotic devices that provide a high level of physical support.
You have a moderate ability to move your arm and hand (scored 32–47 on a specialist assessment), making you eligible for devices that provide a medium level of physical support.
You have a near-normal but still reduced ability to move your arm and hand (scored 48–52 on a specialist assessment), making you eligible for sensor-based devices that provide a low level of physical support.
You have a score of 20 or below on a standard memory and thinking assessment called the MoCA.

Who may not be able to join:

You have severe problems with memory, thinking, or understanding (confirm with trial site).
You have significant difficulties with behaviour (confirm with trial site).
You have significant problems with your senses, such as touch, sight, or hearing (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

IRCCS Centro Neurolesi Bonino Pulejo

Registry

ClinicalTrials.gov

Start date

11 February 2025

Est. completion

11 February 2030

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Between-group difference in change from baseline in Addenbrooke's Cognitive Examination-Revised (ACE-R) total score (Parkinson's disease); Between-group difference in change from baseline in Brief Repeatable Neuropsychological Test (BRNT) composite score (Multiple Sclerosis); Between-group difference in change from baseline in Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) Total Scale Index score (Stroke)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov